We found that the concentrations of five synaptic proteins (VGF, cadherin-2 (CDH2), NPTX2, BDNF and FXYD6) were reduced in preclinical AD relative to controls in EMIF-AD MBD. Here, NPTX2 is linked to Alzheimer disease.